# Pharmacokinetics and Safety Study of Diazepam Buccal Film (DBF) in Pediatric Subjects With Epilepsy

> **NCT03222349** · PHASE2 · COMPLETED · sponsor: **Aquestive Therapeutics** · enrollment: 24 (actual)

## Conditions studied

- Epilepsy

## Interventions

- **DRUG:** Diazepam Buccal Film

## Key facts

- **NCT ID:** NCT03222349
- **Lead sponsor:** Aquestive Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-08-31
- **Primary completion:** 2020-01-28
- **Final completion:** 2020-03-11
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2021-05-26

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03222349

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03222349, "Pharmacokinetics and Safety Study of Diazepam Buccal Film (DBF) in Pediatric Subjects With Epilepsy". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03222349. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*